Brief: Acutus Medical Receives FDA Approval To Initiate US Atrial Fibrillation IDE Trial With Acqblate Force Sensing Ablation System
27/05/2021 13:11
May 27 (Reuters) - Acutus Medical Inc AFIB.O :
* ACUTUS MEDICAL RECEIVES FDA APPROVAL TO INITIATE US ATRIAL
FIBRILLATION IDE TRIAL WITH THE ACQBLATE® FORCE SENSING ABLATION
SYSTEM
* ACUTUS MEDICAL INC - ENROLLMENT FOR ACQBLATE FORCE AF
TRIAL IS
EXPECTED TO BEGIN IN SECOND HALF OF 2021
Source text for Eikon: ID:nGNX2qbsZt
Further company coverage: AFIB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acutus Medical
See all newsBrief: EnChannel Medical Signs Definitive Agreement To Acquire AcQMap Assets From Acutus Medical Inc
Brief: Acutus Medical, On April 30, Nasdaq Notified Co That It Has Not Regained Compliance With Listing Rule
Brief: Acutus Medical- Biotronik Sent A Notice Of Rescission And Termination To Company
Brief: Acutus Medical Says Co's Board Has Fixed Its Size At Six Members
U.S. STOCKS ON THE MOVE-Instacart, Nvidia, Novavax